Detalles de la búsqueda
1.
A prospective trial of abiraterone acetate plus prednisone in Black and White men with metastatic castrate-resistant prostate cancer.
Cancer;
127(16): 2954-2965, 2021 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33951180
2.
Circulating tumor cell-derived organoids: Current challenges and promises in medical research and precision medicine.
Biochim Biophys Acta Rev Cancer;
1869(2): 117-127, 2018 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-29360544
3.
Syntaxin 6-mediated exosome secretion regulates enzalutamide resistance in prostate cancer.
Mol Carcinog;
59(1): 62-72, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31674708
4.
Racial Disparity in Response to Prostate Cancer Systemic Therapies.
Curr Oncol Rep;
22(9): 96, 2020 07 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-32700096
5.
The role of epithelial plasticity in prostate cancer dissemination and treatment resistance.
Cancer Metastasis Rev;
33(2-3): 441-68, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-24414193
6.
Development of a method to isolate circulating tumor cells using mesenchymal-based capture.
Methods;
64(2): 129-36, 2013 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23845299
7.
Toward Informed Selection and Interpretation of Clinical Genomic Tests in Prostate Cancer.
JCO Precis Oncol;
8: e2300654, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38547422
8.
Emerging racial disparities among Medicare beneficiaries and Veterans with metastatic castration-sensitive prostate cancer.
Prostate Cancer Prostatic Dis;
2024 Apr 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38565911
9.
Low-dose Paclitaxel with Pembrolizumab Enhances Clinical and Immunologic Responses in Platinum-refractory Urothelial Carcinoma.
Cancer Res Commun;
4(2): 530-539, 2024 02 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38345536
10.
Genomic classifiers and prognosis of localized prostate cancer: a systematic review.
Prostate Cancer Prostatic Dis;
2024 Jan 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38200096
11.
Marital Status, Living Arrangement, and Survival among Individuals with Advanced Prostate Cancer in the International Registry for Men with Advanced Prostate Cancer.
Cancer Epidemiol Biomarkers Prev;
33(3): 419-425, 2024 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38189661
12.
Transcriptomic Signatures Associated With Outcomes in Recurrent Prostate Cancer Treated With Salvage Radiation, Androgen-Deprivation Therapy, and Enzalutamide: Correlative Analysis of the STREAM Trial.
JCO Precis Oncol;
7: e2300214, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37595184
13.
Study design and methods for the pilot study of muscadine grape extract supplement to improve fatigue among older adult cancer survivors (FOCUS) trial.
J Geriatr Oncol;
14(4): 101478, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36990930
14.
Feasibility of home-based exercise training in men with metastatic castration-resistant prostate cancer.
Prostate Cancer Prostatic Dis;
26(2): 302-308, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35306542
15.
Homologous Recombination Repair Gene Variants and Outcomes Among Patients With Prostate Cancer Treated With Poly (ADP-ribose) Polymerase Inhibitors.
JCO Precis Oncol;
6: e2100461, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35476551
16.
Impact of Race on Outcomes of High-Risk Patients With Prostate Cancer Treated With Moderately Hypofractionated Radiotherapy in an Equal Access Setting.
Fed Pract;
39(Suppl 3): S35-S41, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-36426110
17.
Safety, tolerability and efficacy of agonist anti-CD27 antibody (varlilumab) administered in combination with anti-PD-1 (nivolumab) in advanced solid tumors.
J Immunother Cancer;
10(8)2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35940825
18.
Management of men with metastatic castration-resistant prostate cancer following potent androgen receptor inhibition: a review of novel investigational therapies.
Prostate Cancer Prostatic Dis;
24(2): 301-309, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33168966
19.
Phase I Study of Muscadineâ¯Grape Extract for Patients With Advanced Cancer.
Am J Clin Oncol;
44(6): 239-246, 2021 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33867481
20.
Phase II Trial of Enzalutamide and Androgen Deprivation Therapy with Salvage Radiation in Men with High-risk Prostate-specific Antigen Recurrent Prostate Cancer: The STREAM Trial.
Eur Urol Oncol;
4(6): 948-954, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32063492